CAS RN: 1418274-28-8

Cilofexor

Product Availability

Choose a grade to view its available package options.

11 package records11 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250825 100mg In stock Shanghai Inquiry
Batchno.20260414 10mg In stock Shanghai Inquiry
Batchno.20260313 1mg In stock Shanghai Inquiry
Batchno.20251011 250mg In stock Shanghai Inquiry
Batchno.20250612 25mg In stock Shanghai Inquiry
Batchno.20260608 50mg In stock Shanghai Inquiry
Batchno.20250501 5mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250727 100mg In stock Inquiry
Batchno.20250313 25mg In stock Inquiry
Batchno.20251027 50mg In stock Inquiry
Batchno.20260318 5mg In stock Inquiry
  • Product code: starshine_CAS1418274-28-8
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1418274-28-8 / 2-[3-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]-3-hydroxyazetidin-1-yl]pyridine-4-carboxylic acid

Standard CAS: 1418274-28-8 Multi CAS: No

Basic Information

CAS
1418274-28-8
Multi CAS
No
Molecular Formula
C28H22Cl3N3O5
Molecular Weight
586.800000
Exact Mass
585.062504
SMILES
C1CC1C2=C(C(=NO2)C3=C(C=CC=C3Cl)Cl)COC4=CC(=C(C=C4)C5(CN(C5)C6=NC=CC(=C6)C(=O)O)O)Cl
InChI
InChI=1S/C28H22Cl3N3O5/c29-20-2-1-3-21(30)24(20)25-18(26(39-33-25)15-4-5-15)12-38-17-6-7-19(22(31)11-17)28(37)13-34(14-28)23-10-16(27(35)36)8-9-32-23/h1-3,6-11,15,37H,4-5,12-14H2,(H,35,36)
InChIKey
KZSKGLFYQAYZCO-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
39
Aromatic heavy atom count
23
Fraction Csp3
0.25
Rotatable bonds
8
H-bond acceptors
7
H-bond donors
2
Molar refractivity
147.02
TPSA
108.92

LogP / Solubility

WLOGP
6.56
MLOGP
5.82
XLogP3
5.3
Consensus LogP
5.89
Log S (ESOL)
-7.52
Class (ESOL)
Insoluble
Log S (Ali)
-9.11
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-9.88
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.64

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
5.5

Safety & Transport

Pictogram(s)
Corrosive Acute Toxic Environmental Hazard
Signal
Danger
GHS Hazard Statements
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] H311 (100%): Toxic in contact with skin [Danger Acute toxicity, dermal] H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] H318 (100%): Causes serious eye damage [Danger Serious eye damage/eye irritation] H400 (100%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]
Precautionary Statement Codes
P260, P262, P264, P264+P265, P270, P273, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P361+P364, P363, P391, P405, and P501

Get In Touch

Contact Us